The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Coding Corner Question: Billing for Joint Injection within a Series

Coding Corner Question: Billing for Joint Injection within a Series

January 17, 2019 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A 68-year-old female Medicare patient with a diagnosis of primary osteoarthritis of the left knee returns to a practice for her third injection in a series of knee injections. She reports being able to resume her after-dinner walks, which last for 30–40 minutes at least twice weekly. She denies fevers or any rashes. She has tried multiple weight loss programs, but is having little success because her appetite is unchanged. She denies vomiting, diarrhea, hematochezia, chest pain, dyspnea or other complaints. Ibuprofen (800 mg), acetaminophen and other non-steroidal anti-inflammatory drugs (NSAIDs) have failed to relieve the pain in her knee. The patient’s weight is 220 lbs., height is 5’2″ and BMI is 40.2.

You Might Also Like
  • Coding Corner Answers: Billing for Joint Injection within a Series
  • Rheumatology Coding Corner Question: Coding for a Knee Injection
  • Rheumatology Coding Corner Question: Joint Injection with Ultrasound Guidance, No Office Visit
Explore This Issue
January 2019
Also By This Author
  • Rheumatology Coding Corner Questions: 2017 End-of-Year Quiz

The left knee was injected with 2 mL of hyaluronic acid (Synvisc) under aseptic technique without complications. Due to her weight and her fixed left knee flexion of 13º, the injection was performed with ultrasound guidance. A permanent picture of the injection point was added to the patient’s medical chart.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She was sent home with instructions to rest for 48 hours, to use an ice pack for any swelling and to call if the knee became extremely painful or if she had any systemic symptoms, such as fever.

Diagnoses:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Primary osteoarthritis of left knee
  • Morbid obesity

How should this be coded?

Editor’s note: Case vignettes presented in the Coding Corner are created to illustrate questions about coding. They are not intended to represent the full medical record of a case.

Click here for the answer(s).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Billing/Coding, From the College Tagged With: Joint Injections, Knee Osteoarthritis (OA)Issue: January 2019

You Might Also Like:
  • Coding Corner Answers: Billing for Joint Injection within a Series
  • Rheumatology Coding Corner Question: Coding for a Knee Injection
  • Rheumatology Coding Corner Question: Joint Injection with Ultrasound Guidance, No Office Visit
  • Rheumatology Coding Corner Question: Follow-Up Knee Injection

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)